Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity?
Bipolar disorder and multiple sclerosis: A case series.
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.
Endotoxin-induced systemic inflammation activates microglia: [(11)C]PBR28 positron emission tomography in nonhuman primates.
Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica.
Peptidylarginine deiminase and protein citrullination in prion diseases: Strong evidence of neurodegeneration.
DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
The mediating effect of coping on the association between fatigue and quality of life in patients with multiple sclerosis.
Mechanisms and Pharmacology of Neuropathic Pain in Multiple Sclerosis.
Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy.
Cognitive impairment in patients with multiple sclerosis predicts worse caregiver's health-related quality of life.
Natalizumab (BG00002) Re-Initiation of Dosing. (STRATA)
[Current possibilities of the comprehensive diagnostic assessment in the differential diagnosis of inflammation and tumors of the spine cord.]
Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis.
Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta.
[Vitamin D and multiple sclerosis].
[Compensatory mechanisms in multiple sclerosis(review)].
[The quality of nighttime sleep in patients with multiple sclerosis].
Contribution of genome-wide association studies to scientific research: a pragmatic approach to evaluate their impact.
Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People.
Syringomyelia coexisting with guillain-barre syndrome.
One step forward in the quest for evidence of the efficacy of cognitive rehabilitation in multiple sclerosis.
RANDOM FOREST FLAIR RECONSTRUCTION FROM T 1, T 2, AND PD -WEIGHTED MRI.
Pages
« first
‹ previous
…
340
341
342
343
344
345
346
347
348
…
next ›
last »